February 5, 2026
Angitia Biopharmaceuticals
Angitia Biopharmaceuticals develops biologic therapies fo...
- Round
- Series D
- Amount raised
- $130M
- Lead investor
- Bain Capital Life Sciences
- Industry
- Biopharma, Biotechnology
- Headquarters
- Westlake Village, California
- Employees
- 51-100
- Website
- angitiabio.com
- —